Monitor for any follow-up filings or news that might explain the timing of these sales, but this level of selling by multiple executives is common at large-cap biotech firms and not inherently negative. No material fundamental change is indicated.
Price Chart
Executive Summary
Seven executives at Vertex Pharmaceuticals sold shares in a coordinated cluster over a 3-day window, with total open-market sales amounting to $4.4 million. All transactions were direct sales at market prices, including a $1.2 million sale by the Chief Commercial Officer. The activity represents less than 0.01% of the company's $123.5B market cap and aligns with routine insider selling patterns.
Key Financial Metrics
Key Facts
- 8 open-market share sales by 8 different insiders over 7 days
- Total value of sales: $4,453,244.64
- All sellers are C-suite executives, including EVPs across commercial, legal, scientific, technical, and medical functions
- No purchases, grants, or derivative exercises in the cluster
- Largest sale: Duncan McKechnie (Chief Commercial Officer), $1.216M
- Sales occurred at prices between $480.31 and $486.35 per share
- Total insider sales in the past 30 days now amount to $4.6M
Financial Impact
$4.45 million in open-market sales over 7 days
Risk Factors
- Perception risk if selling continues or accelerates ahead of earnings or regulatory decisions
- Potential misinterpretation by retail investors as a negative signal despite routine nature
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (8 trades, 7d window) | cluster-VRTX-1772573390984 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 7, 2026 12w ago | 8-K | $522.25 $522.81 | ▲ +0.11% | ▼ −1.89% | $506.74 (−2.97%) |
Jul 7, 2026 12w ago | Insider Cluster | $522.25 $522.81 | ▲ +0.11% | ▼ −1.89% | $506.74 (−2.97%) |
Jul 6, 2026 12w ago | Insider Cluster | $529.59 $526.73 | ▼ −0.54% | ▼ −2.26% | $506.74 (−4.31%) |
Jun 3, 2026 17w ago | Insider Cluster | $441.47 $541.69 | ▲ +22.70% | ▲ +21.08% | $506.74 (+14.79%) |
May 19, 2026 19w ago | Insider Cluster | $430.05 $505.75 | ▲ +17.60% | ▲ +12.87% | $506.74 (+17.83%) |
Mar 11, 2026 29w ago | Insider Cluster | $491.96 $428.34 | ▼ −12.93% | ▼ −24.45% | $506.74 (+3.01%) |
Feb 25, 2026 31w ago | Insider Cluster | $482.92 $430.44 | ▼ −10.87% | ▼ −17.82% | $506.74 (+4.93%) |
Feb 25, 2026 31w ago | Insider Cluster | $482.92 $430.44 | ▲ +10.87% | ▲ +17.82% | $506.74 (−4.93%) |
Feb 25, 2026 31w ago | Insider Cluster | $482.92 $430.44 | ▼ −10.87% | ▼ −17.82% | $506.74 (+4.93%) |
Feb 25, 2026 31w ago | Insider Cluster | $482.92 $430.44 | ▼ −10.87% | ▼ −17.82% | $506.74 (+4.93%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access